(Q56352603)
Statements
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study (English)
Margaret A Phillips
Martin Casapia
Raúl Chuquiyauri
Juan-Carlos Hinojosa
Nicola Kerr
Maria Rosario
Stephen Toovey
Robert H Arch
Felix D Rozenberg
Jade Bath
Caroline L Ng
Annie N Cowell
Elizabeth A Winzeler
Mark Baker
Jörg J Möhrle
Nathalie Gobeau
Nada Araeipour
Nicole Andenmatten
Thomas Rückle
Rob Hooft van Huijsduijnen
2 references